Abstract
Gynecomastia and galactorrhea stemming from hyperprolactinemia have been reported in adults after the use of metoclopramide. We describe the cases of an adolescent with gynecomastia and an infant with gynecomastia and galactorrhea that were the result of metoclopramide therapy for gastroesophageal reflux disease.
MeSH terms
-
Adolescent
-
Dopamine Antagonists / adverse effects*
-
Dopamine Antagonists / therapeutic use
-
Galactorrhea / chemically induced
-
Gastroesophageal Reflux / drug therapy
-
Gynecomastia / chemically induced*
-
Humans
-
Infant, Newborn
-
Male
-
Metoclopramide / adverse effects*
-
Metoclopramide / therapeutic use
Substances
-
Dopamine Antagonists
-
Metoclopramide